For health care professionals
Seattle Cancer Care Alliance (SCCA) is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children's and provides a variety of resources for community doctors and other healthcare professionals.
News from our blog
SCCA's main campus offers advanced, leading-edge cancer care, but patients and caregivers outside Seattle may find access to our community sites reduce the burden of travel. Our established community sites across the Puget Sound region offer SCCA's world-class care closer to where patients live. Providers and patients can expect seamless coordination with our South Lake Union campus when patients need more extensive treatment.
Treatment for metastatic kidney cancer is evolving rapidly, as providers move away from performing upfront cytoreductive surgery and navigate a growing number of new therapies and combined drug regimens. SCCA’s Kidney Cancer Multispecialty Clinic (KCMC) offers multidisciplinary consultations and care to help community oncologists and their patients understand and access the latest treatment options.
Join our renowned experts from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and the University of Washington for the 12th Annual Comprehensive Hematology and Oncology Review Course.
Sarcoma: Innovative approaches are transforming care.
The sarcoma treatment landscape is changing dramatically, with a growing number of FDA-approved drugs and clinical trials offering new hope and improving outcomes for patients whose treatment options were very limited just a few years ago.
Journal of Clinical Investigation: Dr. Stanley Riddell, professor (Medical Oncology) is senior author of “A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells”
Subscribe to our SCCA/UWMC clinical trial portfolios
- Skin oncology research portfolio: Contact SLMskin@seattlecca.org
- Monthly email communication includes PDF file of available clinical trials organized by disease setting for melanoma and Merkel cell carcinoma
- GU oncology research portfolio: Contact SLMgu@seattlecca.org
- Monthly email communication includes PDF files of available clinical trials organized by disease setting for prostate, bladder and kidney cancer
- Heme and heme malignancies: Subscribe by signing up for Oncology Insights
- Breast, Heme and heme malignancies: Subscribe by signing up for Oncology Insights
Date: January 29, 2022 from 9:00-10:30am PDT
Featured panelist: Shruti Gupta, MD, MPH; Director of Onco-Nephrology and Associate Physician, Division of Renal Medicine, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Instructor of Medicine, Harvard Medical School
Presenters: Petros Grivas, MD, PhD; Evan Y. Yu, MD